Patterns we observe, exceptions we cannot explain, tensions we hold open, and the variability that makes biology refuse to behave like a flowchart.
Reproducibility states: emerging · recurring · highly-reproducible · destabilizing.
12 entriesInflammation is the substrate of repair; suppressing it impairs resolution.
Sustained inflammation drives barrier loss, fibrosis, and symptom amplification.
Community shifts are downstream consequences of host state and may be appropriate to it.
Specific community shifts are independently causal and worth targeting directly.
Mast cells coordinate barrier defense, parasite expulsion, vascular regulation.
Primed mast cells drive disabling MCAS-pattern symptoms.
Metabolic shifts (e.g., toward glycolysis) preserve function under stress.
Persistent shifts entrench dysfunction by failing to restore oxidative throughput.
Most chronic recurrence reflects upstream host-capacity failure.
Specific microbial states drive disease independently.
Reducing symptom load is itself therapeutic and improves quality of life.
Suppression without addressing upstream state can entrench instability.
A subset of patients with classic recurrent SIBO + MCAS-like overlap recover durably with only lifestyle changes (sleep, sun, walking).
If host capacity were always primary, generic restoration should not be sufficient at this rate.
Likely captures patients whose deficit was modest and whose ecological state was still resilient. Boundary case, not refutation.
Some patients achieve >2-year remission with a single rifaximin course and no further work.
Framework predicts that without restoring host capacity, recurrence should dominate.
May reflect cases where dysbiosis was the primary insult and host capacity was preserved. Suggests phenotypic heterogeneity within the SIBO label.
Patients with disabling MCAS symptoms and entirely normal gut workup.
Framework hypothesizes shared upstream barrier-and-bioenergetic failure.
Either gut signal is below detection of standard workup, or these represent a non-gut MCAS subtype outside framework scope.
Stool sequencing shows preserved Faecalibacterium / Roseburia, yet patient has classic recurrent symptoms.
Framework predicts ecological signature should track with symptoms.
Stool may not reflect mucosa-adherent populations; or the symptom set has a non-ecological driver.
Polymorphisms in mitochondrial complexes, detoxification enzymes, mast-cell mediators, and barrier proteins.
Pre-illness mitochondrial density and respiratory capacity.
Baseline regulatory tone, prior infection load, vaccine history, autoimmune background.
Starting community composition, diversity, keystone species presence.
Substrate supply for mitochondrial throughput and barrier maintenance (B-vitamins, iron, fatty acids, amino acids).
Splanchnic blood flow, altitude, exercise pattern, sleep apnea status.
Chronic low-grade inflammation from any source (adipose, infection, autoimmunity).
These categories describe how an observation entered the Observatory and how repeatedly it has been seen. They are not controlled epidemiological estimates and are not diagnostic claims.
Pattern has formal support in the published research literature; the Observatory entry summarizes a reading of that literature.
Observed across multiple Biomelogic consultations. Not an epidemiological estimate. No personally identifying detail is reproduced.
Aggregated from public communities, patient forums, and shared clinical correspondence. Subject to selection bias.
Derived by mapping signals onto the Host Capacity Model. Hypothesis-grade; not a measurement.
Recently noticed; reproducibility still being assessed. Open to revision or removal.
An exception or contradiction without a current working explanation. Held open rather than resolved prematurely.